Non-Cochrane · intervention · PM41893203

Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry.

Cabrera-Fernández Alberto, Dominguez-Dominguez Laura, Pérez-Pérez Antonio, et al. · Journal of functional biomaterials · 2026 · PubMed · doi:10.3390/jfb17030147

Findings

6 findings

Population
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis)TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy)Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Overall clinical and radiographic success
<360 days
RR 0.99 [0.96, 1.02]
-10 [-40, 20] per 1000
Low
Downgraded: risk of bias, imprecision
7 studies · 400 participants
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis)TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy)Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Overall clinical and radiographic success
>=360 days
RR 0.95 [0.89, 1.01]
-46 [-101, 9] per 1000
Low
Downgraded: risk of bias, imprecision
5 studies · 355 participants
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis)TheraCal LC (resin-modified calcium silicate) for indirect pulp cappingNon-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Overall clinical and radiographic success
<360 days · Procedure: Indirect pulp capping
RR 0.99 [0.95, 1.03]
-10 [-50, 30] per 1000
Low
Downgraded: risk of bias, imprecision
5 studies · 218 participants
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis)TheraCal LC (resin-modified calcium silicate) for indirect pulp cappingNon-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Overall clinical and radiographic success
>=360 days · Procedure: Indirect pulp capping
RR 0.94 [0.86, 1.03]
-57 [-132, 28] per 1000
Low
Downgraded: risk of bias, imprecision
2 studies · 153 participants
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis)TheraCal LC (resin-modified calcium silicate) for pulpotomyNon-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Overall clinical and radiographic success
>=360 days · Procedure: Pulpotomy
RR 0.95 [0.85, 1.06]
-43 [-128, 51] per 1000
Low
Downgraded: risk of bias, imprecision
2 studies · 124 participants
Primary teeth with deep caries and vital pulp (healthy pulp or reversible pulpitis) requiring vital pulp therapyOther resin-modified calcium silicate materials (TheraCal PT, BioCal-CAP, Oxford ActiveCal CP)Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine)Combined clinical and radiographic successno estimate extracted
No studies found
0 studies

Included primary studies 9

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Gurcan 2019
Clinical and radiographic evaluation of indirect pulp capping with three different materials: a 2-year follow-up study.
PMID:31246084
20191 other reviewOverall clinical and radiographic successnot extracted yet
Abdelhafez 2022
matched by author and year (probable)
NRthis review onlyOverall clinical and radiographic successnot extracted yet
ElHameed 2025
Clinical and radiographic evaluation of indirect pulp capping using biodentine and theracal LC in primary molars
DOI:10.4103/tdj.tdj_46_24
2024this review onlyOverall clinical and radiographic successnot extracted yet
Erfanparast 2018
Direct pulp capping in primary molars using a resin-modified Portland cement-based material (TheraCal) compared to MTA with 12-month…
PMID:29767382
2018this review onlyOverall clinical and radiographic successnot extracted yet
Hassanpour 2023
Comparison between the Radiographic and Clinical Rates of Success for TheraCal and MTA in Primary Tooth Pulpotomy within a 12-Month…
PMID:37124935
2023this review onlyOverall clinical and radiographic successnot extracted yet
Menon 2016
Clinical and radiographic comparison of indirect pulp treatment using light-cured calcium silicate and mineral trioxide aggregate in…
PMID:27994414
2016this review onlyOverall clinical and radiographic successnot extracted yet
Sahin 2021
Clinical, radiographic, and histological evaluation of three different pulp-capping materials in indirect pulp treatment of primary teeth:…
PMID:33404764
2021this review onlyOverall clinical and radiographic successnot extracted yet
Saikia 2023
Evaluation of Indirect Pulp Capping Using MTA, Light-cured Calcium Silicate, and Propolis in Primary Teeth: A Clinical and Radiographic…
PMID:38162240
2023this review onlyOverall clinical and radiographic successnot extracted yet
Thomas 2024
Comparative Evaluation of Effectiveness of Calcium Hydroxide, MTA, and TheraCal LC in Indirect Pulp Capping in Primary Molars: In Vivo…
PMID:38956853
2024this review onlyOverall clinical and radiographic successnot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationPrimary teeth with deep carious lesions and vital pulp (healthy pulp or reversible pulpitis) treated by vital pulp therapyPrimary teeth with reversible pulpitis or normal pulp, aged 3 to 15 years (n=40 to 295 teeth per trial)
InterventionResin-modified calcium silicate-based materials (e.g., TheraCal LC, TheraCal PT, BioCal-CAP) in vital pulp therapyTheraCal LC only (n=9 trials); IPC, DPC and pulpotomy
ComparisonConventional resin-free calcium silicate-based materials (Biodentine, ProRoot MTA, MTA Angelus)MTA ProRoot (n=4), MTA Angelus (n=3), Biodentine (n=2)
OutcomesPrimary: overall clinical and radiographic success at 3 to 36 months; secondary: increase in dentin thicknessCombined clinical and radiographic success (meta-analyzed); dentin thickness (4 trials, narrative only)
Study designsRandomized clinical trials (parallel-group or split-mouth)Randomized clinical trials (n=9)
TimingFollow-up 3 to 36 monthsFollow-up 90 to 720 days

AMSTAR 2 items

Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.

ItemExtractor AExtractor BAgree
1Research question includes PICO componentsYesYesyes
2Protocol established before the reviewcriticalYesPartial Yesno
3Choice of study designs explainedNoNoyes
4Comprehensive literature searchcriticalYesPartial Yesno
5Study selection in duplicateYesYesyes
6Data extraction in duplicateYesYesyes
7List of excluded studies with reasonscriticalNoNoyes
8Included studies described in detailPartial YesPartial Yesyes
9Risk of bias assessed satisfactorilycriticalNRSI: N/A · RCT: YesRCT: Yes · NRSI: N/Ano
10Funding of included studies reportedNoNoyes
11Appropriate meta-analysis methodscriticalRCT: Yes · NRSI: N/ARCT: Yes · NRSI: N/Ayes
12Impact of risk of bias on the pooled resultsNoNoyes
13Risk of bias accounted for in interpretationcriticalYesYesyes
14Heterogeneity explainedYesYesyes
15Publication bias investigatedcriticalNoNoyes
16Conflicts of interest reportedYesYesyes
OverallCritically LowCritically Lowyes